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Abstract
Background: Intermittent preventive treatment (IPT), the main strategy to prevent malaria and reduce anaemia and low
birthweight, focuses on the second half of pregnancy. However, intrauterine growth restriction may occur earlier in
pregnancy. The aim of this study was to measure the effects of malaria in the first half of pregnancy by comparing the fetal
biparietal diameter (BPD) of infected and uninfected women whose pregnancies had been accurately dated by crown rump
length (CRL) before 14 weeks of gestation.
Methodology/Principal Findings: In 3,779 women living on the Thai-Myanmar border who delivered a normal singleton
live born baby between 2001–10 and who had gestational age estimated by CRL measurement ,14 weeks, the observed
and expected BPD z-scores (,24 weeks) in pregnancies that were (n=336) and were not (n=3,443) complicated by malaria
between the two scans were compared. The mean (standard deviation) fetal BPD z-scores in women with Plasmodium (P)
falciparum and/or P.vivax malaria infections were significantly lower than in non-infected pregnancies; 20.57 (1.13) versus
20.10 (1.17), p,0.001. Even a single or an asymptomatic malaria episode resulted in a significantly lower z-score. Fetal
female sex (p,0.001) and low body mass index (p=0.01) were also independently associated with a smaller BPD in
multivariate analysis.
Conclusions/Significance: Despite early treatment in all positive women, one or more (a)symptomatic P.falciparum or
P.vivax malaria infections in the first half of pregnancy result in a smaller than expected mid-trimester fetal head diameter.
Strategies to prevent malaria in pregnancy should include early pregnancy.
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Introduction
Malaria remains one of the most common parasitic infection of
human pregnancy [1–4], and it lowers birthweight whether or not
maternal symptoms are present [5]. Even a single episode of
treated Plasmodium (P.) falciparum or P.vivax malaria during
pregnancy has a negative effect on birthweight [6,7]. The
mechanisms of this reduction in birthweight include placental
insufficiency by sequestration of malaria parasites leading to
intrauterine growth restriction (IUGR), premature labour or a
combination of the two [8,9]. The evidence is less clear in P.vivax
infected pregnancies where placental sequestration is probably
limited [10]. Difficulties in estimating gestational age (GA)
accurately and diagnosing malaria infection in early pregnancy
have complicated the interpretation of previous malaria studies on
fetal growth [9,11]. IUGR may start in the first trimester and
influence late pregnancy outcomes [12]. Early antenatal ultra-
sound - which is essential to date pregnancy accurately [13] - is
becoming available in developing countries [14–16]. The aim of
this study was to assess whether malaria infection affects early fetal
growth by comparing the fetal biparietal diameter (BPD) before 24
weeks gestation in infected and uninfected women whose
pregnancies had been accurately dated by crown rump length
(CRL) measurement before 14 weeks.
Methods
Study site and population
The Shoklo Malaria Research Unit (SMRU) is located on the
border between Thailand and Burma in Tak province where the
majority of people belongs to the Karen ethnic group [17].
P.falciparum [18] and P.vivax [7] transmissions are low and seasonal
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to refugees and later (1998) to migrant women, including weekly
malaria screening to detect and treat all parasitaemic episodes
during pregnancy in order to prevent maternal death [18]. There
is no presumptive treatment of malaria, chemoprophylaxis or
intermittent preventive treatment in pregnancy due to drug
resistance. Since the inception of this ANC program, all pregnant
women have been encouraged to attend as early as possible in the
first trimester. In 2001 antenatal ultrasound was introduced to
improve pregnancy dating in this population because of low
literacy rates and poor recall of the date of the last menstrual
period [14,20]. At enrolment in the antenatal clinic all women are
interviewed for demographics and have anthropometric measure-
ments taken. At every visit ferrous sulphate (200 mg daily) and
folic acid (5 mg weekly) for anemia prophylaxis and thiamine
(Vitamin B1, 100 mg daily) to prevent infant mortality from beri-
beri [21] are offered to all women. Anaemic women receive
treatment doses of ferrous sulphate (200 mg three times daily) and
folic acid (5 mg daily). All medical and obstetric problems in
pregnancy are investigated and treated free of charge by locally
trained health workers working in SMRU facilities [22,23].
Pregnancy ultrasound
Locally trained health workers (10 sonographers at 3 clinics)
obtain all ultrasound scans using Toshiba Powervision 7000 (since
2006), Dynamic Imaging (since 2001), Fukuda Denshi UF 4100
(since 2002) ultrasound machines. Their practice is supervised by
doctors certified in fetal ultrasonography. All women are offered
two scans in pregnancy. The 1
st scan occurs at the booking visit
(between 8–14 weeks gestation) where ultrasound is used to
determine viability, identify multiple pregnancy and estimate GA
by CRL measurement. Based on this GA estimate women then
return for a 2
nd scan performed at 18–24 weeks to re-assess
viability, measure fetal biometry, identify major fetal abnormalities
and determine placental location. Fetal biometry is routinely
measured twice in each woman at each scan, as part of an existing
quality control [14].
The training manual and protocol for obtaining trans-
abdominal CRL and biometry measurements were from the
British Medical Ultrasound Society recommendation [24].
The BPD is measured at the cross-sectional view of the fetal
head at the level of the ventricles by placing the calipers on the
outer border of the upper and the inner border of the lower
parietal bones (‘outer to inner’, BPD) across the widest part of the
skull. Importantly for this study, operators taking fetal measure-
ments were not aware of the maternal malaria status.
Outcomes and SMRU delivery rooms
All women are encouraged to deliver in the SMRU facilities
under supervision of locally trained midwives who speak their
language. Women requiring Caesarean section are referred to the
nearest Thai hospital; in this study the Caesarean section rate was
3.4% (129/3,779). Each baby is weighed within 24 hours on
electronic SECA (Model 336 or 376, accuracy=10 g) digital
newborn scales.
Ethics statement
This is a retrospective hospital record analysis. For those
patients in trials a written informed consent was obtained
including storing of data and samples. For the women seen in
the ANC the routine clinical records were anonymized and these
pregnancy records have been routinely entered into a database
since 1987. Permission was granted by Oxford Tropical Research
Ethics Committee (reference: OXTREC 28–09) to use these
records for analysis.
Diagnosis of malaria
Malaria is diagnosed by Giemsa stained thick and thin blood
films; 200 fields on the thick film are read before being declared
negative. All parasite densities are counted per 500 white blood
cells or per 1000 red blood cells. P. vivax or P. falciparum malaria
infection is defined by the presence of asexual stages of the
respective parasite in the peripheral blood.
Definitions
Severe malaria is defined as per WHO treatment guidelines
[25] and hyperparasitaemic malaria by the presence of at least 4%
infected red blood cells in the absence of other signs of severity.
Anaemia is defined by a haematocrit less than 30%. Symptomatic
malaria is defined by a temperature $37.5uC or a history of fever
[25]. When a women had at least one symptomatic episode
between the 1
st and the 2
nd scan she was classified as symptomatic.
Mid Upper Arm Circumference (MUAC) was measured at the
first ANC consultation on an unclothed left arm with a SECA
measuring tape (model 212) accurate to one mm and low MUAC
is defined as ,21.0 cm [26]. Maternal height is measured at the
first ANC consultation and short stature is defined as ,145 cm.
Maternal weight of women wearing the lightest possible clothing,
is measured at the first consultation and at the time of the biometry
ultrasound scan on mechanical SECA weight scales (model 762)
with graduation of 500 grams. Weight gain is defined as the
difference in maternal weight between the two scans. The weight
in the first trimester is used to calculate the body mass index
(BMI): a BMI of ,18.5 kg/m2 is considered underweight [27].
Pregnancy duration is defined as 280 days post menstruation.
Miscarriage is a pregnancy ending before 28 weeks GA and
stillbirth a delivery from 28 weeks or $800 g birthweight in which
the infant displayed no sign of life (gasping, muscular activity,
cardiac activity). The 28-week GA, rather than the current WHO
22-week GA cut-off was chosen, as no infant ventilatory support is
available in the clinics. This cut-off has been in place since SMRU
was established as the lower limit of viability in this area.
Congenital abnormality is considered if any major abnormality
was present at birth by staff trained in examination of the
newborn.
Inclusion and Exclusion criteria
All women who had GA estimated by CRL measurement ,14
weeks (1
st scan) and BPD measured ,24 weeks (2
nd scan), were
included in the analysis. Twin pregnancies, pregnancies that were
complicated by miscarriage, stillbirth or fetal structural abnormal-
ities and pregnancies with an unknown outcome were excluded
(Figure 1). Women who had their first malaria episode before or at
the time of the 1
st scan or after the 2
nd scan were also excluded.
Therefore in this analysis all malaria infected women had their
first malaria episode between the first and the second ultrasound
scans. For the analysis of birth outcomes women who had another
episode after the second scan were excluded to avoid the
confounding effects of malaria outside the window of measure-
ment (14
+0–24
+0 weeks).
Statistical Analysis
Clinical data and the results of the two ultrasound scans were
entered into a Microsoft Access database and analyzed using SPSS
version 18 for Windows. Student’s t-test and Mann-Whitney test
were used for comparison of means and ranks respectively.
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Fisher’s exact test, as appropriate. The mean of two CRL
measurements was used to calculate GA in days using a well
established formula [28]. The average of two BPD measurements
was recorded as ‘BPD observed’. For the purpose of this study the
‘expected BPD size’ for each GA was calculated using a reference
equation for the Karen population [29]. For validation purposes
all analyses were repeated for z-scores derived from a chart based
on an ethnic Chinese population [30].
Each observed BPD was then converted into a z-score using the
following formula:
z-score~ BPD observed{BPD expected ðÞ =SD,
where SD is the standard deviation of the BPD at that GA. The
advantage of converting measurements into z scores is that it
eliminates variability by GA allowing measurements to be
compared [31,32]. A positive z-score indicates a larger and a
negative value a smaller than expected BPD.
In order to assess the impact of malaria infection on fetal growth
during early pregnancy, the mean BPD z-scores were compared in
women who did and did not have peripheral parasitaemia in the
window between the 1
st and 2
nd scans. Other factors associated
with BPD were evaluated by univariate analysis; variables with a
significance of P,0.1 were kept in the multivariate regression
model. A secondary endpoint was the effect of malaria infection
between the 1
st and 2
nd scan only, on GA and birthweight at
delivery. For this purpose a population birthweight centiles chart
(per gestational age) was computed from all pregnancies in SMRU
with accurate ultrasound dating. Only newborns who were
weighed within the first 24 hours after delivery were included [11].
Results
Between September 2001 and January 2010, 4,580 women had
a1
st (CRL measurement ,14 weeks) and a 2
nd scan (BPD
measurement ,24 weeks). Women with an unknown pregnancy
outcome (410, 9.0%) were excluded from further analysis; they
were more likely to be younger and primigravid, to book at a lower
GA and have malaria (data not shown). A further 391 women
(8.5%) were excluded for miscarriage/stillbirth (n=40), congenital
abnormality (n=52), twin pregnancy (n=12), first malaria before
the CRL dating scan (n=96) or first malaria infection after the
BPD scan (n=191) (Figure 1). There were three maternal deaths:
two women died from post-partum hemorrhage after delivering
stillborn infants (excluded from analysis due to stillbirth); one
woman died of severe malaria five weeks post-partum and was
included as the infant was live born. Therefore, a total of 3,779
women remained for analysis.
Figure 1. Selection of pregnant women.
doi:10.1371/journal.pone.0031411.g001
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The median number of antenatal visits was 23 [range 3–38]. At
each visit a malaria smear was obtained and malaria parasites
were detected in 930 (1.1%) of the available 86,416 blood slides;
these were from 336/3,779 (8.9%) women. The median number
of malaria episodes per woman was 2 [range 1–8] for the duration
of pregnancy.
Timing of Malaria episodes
The 336 women who had their first malaria infection in the
window between the two scans had a lower BMI, a lower Hct and
were younger and more likely to smoke, than the 3,443 uninfected
women (Table 1). Of the 336 women with malaria, 240 (71.4%)
had only P.vivax infections and 96 (28.6%) had P.falciparum or both
infections (Table 2). In 233 (69.3%) there was a single malaria
infection in the window between the two scans; of these 80.3%
(187/233) were P.vivax. Multiple malaria infections [range 2–4] in
the window were diagnosed in 103 women (30.7%). There were
only six women (1.8%) with a hyperparasitaemic P.falciparum
infection in the window and no severe malaria infections (Table 2).
Only 114 (33.9%) women had all their episodes of malaria
between the two scans and none after the second scan.
Effect of malaria on BPD
The BPD measurements of malaria infected and uninfected
women were superimposed on the 2.5
th,5 0
th, and 97.5
th centiles of
the reference equation [29] and presented graphically between 16
and 24 weeks GA to allow visual comparison (Figure 2). Most of
the BPD measurements of women with malaria (red diamonds)
were below the 50
th centile (Figure 2 and insert, which shows the
BPD measurements between 17 and 20 weeks GA in which 90%
(302/336) of the measurements were obtained). The BPD
measurements were then converted into z-scores that were
normally distributed. There was a statistically significant difference
between the mean (SD) BPD z-scores of the fetuses of infected and
uninfected women (20.57 (1.13) versus 20.10 (1.17), p,0.001)
(Figure 3, Table 3). Both P.falciparum (or mixed) (n=96) and P.vivax
(n=240) were associated with a lower mean z-score than
uninfected women (20.45 (1.2), p=0.006 and 20.62 (1.1)
respectively, p,0.001). There was no significant difference in
mean (SD) z-scores between women with symptomatic (n=165) or
asymptomatic malaria (n=169) episodes: 20.59 (1.1) versus
20.54 (1.2) respectively, p=0.68. Women with multiple malaria
infections (n=103) had the lowest mean (SD) z-scores (20.72 (1.0),
p,0.001) but even a single malaria episode between the 2 scans
(n=233) resulted in a significantly lower mean (SD) BPD z-score:
20.51 (1.2), p,0.001). There was no significant difference in
mean z-scores between women with uncomplicated and hyper-
parasitaemic malaria, but the number of hyperparasitaemic
women was too small for analysis (Table 2).
Aside from malaria, female sex of the fetus, maternal anaemia
and low maternal BMI were also significantly associated with a
lower mean z-score in the univariate analysis. These remained
independent risk factors in the linear regression model which
included 2972 women, the remainder being excluded because of
missing values mainly maternal weight at the second scan (Table 3).
This significantly lower mean BPD z-score (difference in z-score of
0.47 SD) means that malaria during the period between the two
scans reduces the diameter of the fetal head by approximately
1 mm when measured at a GA of 22 weeks. The same analysis was
repeated for z-scores derived from a Chinese population and
except for a small shift in mean z-score (as expected for different
populations) the magnitude and significance of the differences
were similar (Supporting File S1 and Supporting Table S1).
Effect of malaria on birth outcomes
Of the 3,083 live born congenitally normal singleton infants
weighed within 24 hours of delivery, the z-score for BPD was
positively correlated with birthweight centile: B=0.168 (95% CI
0.128–0.209), p,0.001. Seventy two of the 114 women (63.2%)
who had all their malaria infections between the two scans only,
had their baby weighted within 24 hours. Neonates from these
pregnancies had similar birth outcomes as the ones from
uninfected pregnancies (n=3,011): mean (SD) birthweight 2919
(SD 533) g versus 2973 (SD 433) g, p=0.40, mean GA 272 (SD
13) days (or 38.9 (SD 1.9) weeks) versus 273 (SD 11) days (or 39.0
(SD 1.6) weeks), p=0.22 and birthweight centile 0.00 (SD 1.2)
versus 0.03 (SD 1.0) respectively. Within this small malaria sub-
group (n=72) there was no association between BPD z-score and
birthweight centile.
Discussion
In this study a significantly smaller fetal BPD was observed by
ultrasound when malaria infection occurred in the first half of
pregnancy, compared to pregnancies unaffected by malaria.
Previous studies have shown that malaria early in pregnancy has
an impact on birthweight, but they were limited by small numbers
of first trimester exposures [33] or by inaccuracy in the dating of
gestation [34]. In this analysis the women had a documented and
treated episode of malaria during a specific period between two
ultrasound scans. By studying this selected group the effects of
malaria on fetal growth could be quantified in-utero. Even a single
infection of treated P.vivax or P.falciparum was associated with
reduced BPD irrespective of whether the woman was symptomatic
or not. The mechanisms underlying the adverse effects of malaria
in pregnancy are not fully understood [7,35,36]. P.falciparum is
thought to sequester in the placenta and interfere with materno-
Table 1. Demographics of the refugee and migrant women
from Thai Burmese border, 2001–2010.
Malaria
+ No Malaria P value
n=336 n=3,443
Age, years 24.0 20–30 26.0 21–31 0.006
Gravida 3 1–4 3 2–4 0.187
Parity 1 [0–3] 1 [0–3] 0.036
Nulliparous, % (n) 28.3 (95) 24.3 (836) 0.105
Height, cm
$ 151 [148–155] 151 [147–155] 0.349
BMI, kg/m
2$ 20.0 [18.6–21.5] 20.5 [19.0–22.4] ,0.001
Weight gain, kg* 2.0 [1.0–3.0] 2.0 [1.0–3.0] 0.265
Hct, % 28 (26–30) 30 (28–32) ,0.001
MUAC, cm
# 24.3 [23.0–26.0] 24.0 [22.8–26.0] 0.483
Smoker, % (n) 30.7 (103) 22.5 (773) 0.001
NOC during pregnancy 23 19–28 23 17–29 0.485
Median [IQR], or as indicated.
BMI body mass index, Hct Haematocrit at first consultation, MUAC middle
upper arm circumference, NOC number of consultations.
+between the 1
st and 2
nd scans.
*Weight gain from the first to the second scan; available from 301 in malaria
and 2,677 in no malaria group.
#Available from 292 in malaria and 2,626 in no malaria group.
$Available from 314 in malaria and 3,044 in no malaria group.
doi:10.1371/journal.pone.0031411.t001
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Systemic or hormonal mechanisms may play a role in P. vivax
related growth restriction, as there is little evidence that P.vivax
sequesters in the placenta, like P.falciparum does [7,10,35,36]. In
non-malaria endemic areas, early pregnancy growth restriction
has been associated with miscarriage [37], maternal physical
characteristics and lifestyle habits related to early fetal growth [38],
and low BPD growth rates between the first and second trimester
are associated with increased perinatal mortality and IUGR
[39,40]. In malaria endemic areas ultrasound studies have related
malaria in pregnancy to changes in maternal and fetal blood flow
[41,42] and associated malnutrition and malaria in pregnancy
with IUGR [43]. So the results presented here are not entirely
unexpected but show for the first time the direct evidence of the
effect of malaria (both falciparum and vivax) on fetal growth. More
surprising perhaps is that low BPD growth was observed after a
single (even asymptomatic) infection and despite early treatment.
Studies on the impact of malaria in pregnancy have almost
always focused on birthweight. However, for infections that occur
in early pregnancy, the size of the fetal head may be a more
appropriate indicator of growth restriction. It has been shown that
the growth velocity of the fetal head (in mm/day) is maximal
during the second trimester [44–46]. In contrast the fetal ‘‘weight
velocity’’ (in g/week) peaks in the third trimester. This weight gain
velocity curve has often been cited wrongly as a fetal ‘‘growth
velocity’’ curve [47,48]. The characteristics of the ‘‘fetal head size’’
and ‘‘fetal weight’’ growth velocity curves are similar but the
timing is different. One of the strengths of this study is that the
timing of the BPD measurement coincided with the maximal
growth velocity of the fetal head, making it a better marker of the
effect of malaria in early pregnancy than birthweight.
The reduction in BPD size occurred despite prompt treatment
with effective antimalarials in this setting, which highlights the
importance of prevention in pregnancy. Multiple episodes of
P.vivax are most likely from liver stage relapses instead of newly
acquired infections. There is no treatment available in pregnancy
for liver stages. Furthermore, in this setting of multidrug resistant
parasites there are no safe and effective drugs available to prevent
Table 2. Species, episodes and severity of malaria and mean BPD z-score of women infected between the first and second scan.
Total malaria
episodes
P.falciparum or
mixed P.vivax
Proportion of women with
one episode
Proportion women at least
one symptomatic episode
Proportion at least one
hyper/severe episode
N=336 N=96 N=240 N=336 N=334
# N=336
Between 1
st
and 2
nd scan
1 1–4 1 1–3 1 1–4 69.3% (233) 49.1% (165) 1.8% (6)
Mean BPD
z-score
20.57 (1.1) 20.45 (1.2) 20.62 (1.1) 20.51 (1.2) 20.59 (1.1) n.a.
Median [min-max], or mean (SD). BPD biparietal diameter; hyper=hyperparasitaemia ($4% red blood cells infected), n.a. not applicable, P plasmodium.
#Missing data n=2.
doi:10.1371/journal.pone.0031411.t002
Figure 2. Fetal biparietal diameter measurements in Burmese and Karen pregnant women with and without malaria. The x-axis shows
the gestational age (GA) in weeks, based on first trimester dated pregnancies on the Thai-Burmese border from 2001 to 2010. The y-axis depicts the
fetal biparietal diameter measurement (BPD) in centimeters. The fetal BPD in pregnant women with malaria (red diamonds, n=336) and in women
without malaria (+, n=3,443) between 16 and 24 GA weeks were superimposed on the 2.5
th,5 0
th and 97.5
th centiles of a reference equation for this
population [29]. Note that the majority of fetal BPD measurements in malaria infected women lie below the 50
th centile in both the main figure (16 to
24 GA weeks) and in the inset (17 to 20 GA weeks, where 90% (302/336) of the measurements in malaria infected women were obtained).
doi:10.1371/journal.pone.0031411.g002
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fetus from growth restriction from both symptomatic and
asymptomatic P.vivax and P.falciparum infections, prevention
strategies from early pregnancy onwards or even pre-pregnancy
interventions should be considered [33,34,49,50].
There are some limitations to this analysis. Firstly, although
dating by CRL is generally considered to be the most accurate
method of estimating GA, some factors that may have had an
impact on CRL dating, for example maternal age [51] or
haematocrit [38]. Such factors are difficult to control for in this
type of population because the date of the last menstrual period is
often not available. The second limitation is that the observed
difference in BPD is small and within the range of error for most
ultrasound machines and sonographers. The scans were obtained
by locally trained technicians who were previously reported to
have a mean difference of 0.43 (SD 1.21) mm in their BPD
measurements in scans between 18 and 24 weeks, corresponding
to 0.12 (SD 0.36) weeks [14]. The observed reduction in BPD in
malaria infected pregnancies at 22 weeks is within the range of this
measurement error. However the data of this retrospective analysis
were derived from the entire population of women attending ANC
for their routine ultrasound scans, which minimizes selection bias.
In addition the sonographers were not aware whether women had
malaria or not during pregnancy and therefore observer bias is
unlikely. If there was no true effect of malaria infection on BPD
any observed difference would likely be occulted by the expected
Figure 3. Z-scores of fetal biparietal diameter in Burmese and
Karen pregnant women with and without malaria. The x-axis
shows the z-score and the y-axis depicts the distribution in percentages.
The distribution of z-scores of fetal biparietal diameter in pregnant
women with malaria (n=336, red bars) is significantly lower than in
women without malaria (n=3,443, grey bars) on the Thai-Burmese
border from 2001 to 2010.
doi:10.1371/journal.pone.0031411.g003
Table 3. Risk factors associated with mean BPD z-score as a measure of early fetal growth restriction.
Univariate Multivariate (n=2972)
Frequency (%) Coefficient (95% CI) P-value Coefficient (95%CI) P-value
Teenager No 3,210 (84.9)
Yes 569 (15.1) 20.02 (20.13, 0.08) 0.66 * NS
Primigravida No 2,848 (75.4)
Yes 931 (24.6) 0.07 (20.02, 0.16) 0.10 * NS
Smoking No 2,893 (76.8)
Yes 876 (23.2) 0.04 (20.05, 0.12) 0.43 * NS
Low MUAC No 2,801 (96.0)
Yes 116 (4.0) 0.07 (20.14, 0.29) 0.51 * NS
Short No 2,995 (89.2)
Yes 362 (10.8) 0.04 (20.09, 0.16) 0.58 * NS
Low BMI No 2,738 (81.6)
Yes 619 (18.4) 0.18 (0.08, 0.28) 0.001 0.15 (0.04, 0.26) 0.005
Weight loss No 2,396 (80.5)
Yes 581 (19.5) 0.09 (20.02, 0.19) 0.10 0.11 (0.00, 0.21) 0.05
Anaemia No 2152 (56.9)
Yes 1627 (43.1) 0.16 (0.09, 0.24) ,0.001 $
Malaria No 3,443 (91.1)
Yes 336 (8.9) 0.47 (0.34, 0.60) ,0.001 0.50 (0.36, 0.63) ,0.001
Symptomatic malaria No 169 (50.6)
Yes 165 (49.4) 0.05 (20.19, 0.30) 0.68 * NS
Newborn gender M 1,936 (51.2)
F 1,843 (48.8) 0.25 (0.18, 0.33) ,0.001 0.25 (0.17,0.34) ,0.001
Significant differences are shown in bold.
BMI body mass index, MUAC middle upper arm circumference, NS not significant.
*Not included in the multivariate analysis.
$Anaemia was highly collinear with malaria, and the co-variates in the multivariate model were unchanged when anaemia was adjusted for or not.
doi:10.1371/journal.pone.0031411.t003
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population of routine ultrasound scans, malaria in the late first
and/or second trimester was the largest risk factor for a smaller
BPD. Thirdly, in order to examine the effect of the malaria
between the scans on birth outcomes, a highly selected group of
women was studied for this analysis. This small group (N=72) had
their malaria infections only between the two scans, and was
malaria free in the time period where weight gain velocity is
highest. Therefore no firm conclusions on the relationship between
malaria in early pregnancy, its impact on BPD and birth outcome
can be drawn from this analysis. Finally, other biometric
parameters, such as fetal head circumference, were not available
for most women.
Intermittent preventive treatment, one of the main WHO
recommended strategies for malaria prevention and control during
pregnancy in areas of stable malaria transmission, aims to provide
two or three treatment doses after quickening (around 20 weeks
GA) at least one month apart [48]. This approach fails to protect
women in the gestational weeks of the highest fetal head growth
velocity. Fetal growth has been postulated to be a dynamic system
where pulsatile characteristics of saltatory growth events are able
to change throughout pregnancy [52–55]. Such pulsatile growth
events all the way through pregnancy stress the importance of
protecting each fetus from the effects of malaria parasites starting
as early as possible in pregnancy.
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